Side effects associated with itraconazole therapy
Side effects were experienced by approximately one-quarter of patients with histoplasmosis receiving long-term itraconazole therapy. About two-thirds of these patients had a therapeutic intervention. Itraconazole resulted in a lower frequency of side effects than fluconazole, as measured in other studies.
Authors
- Julio Cesar Zuniga-Moya (ORCID: https://orcid.org/0000-0002-8561-5463)
- Patrick B Mazi (ORCID: https://orcid.org/0000-0003-4123-0518)
- Andrej Spec (ORCID: https://orcid.org/0000-0001-7612-4710)
- Adriana M. Rauseo (ORCID: https://orcid.org/0000-0001-9555-2550)
- Matthew R. Osborn (ORCID: https://orcid.org/0000-0002-5979-3311)
Institutions
- Washington University in St. Louis (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1093/jac/dkae437
- Citations
- 11
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 4.28
Funders
- Cidara Therapeutics
- Astellas Pharma